Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS
Content archived on 2024-06-16

Novel testing strategies for in vitro assessment of allergens

Objective

Allergies to sensitising agents are steadily increasing. Risk assessment for potential skin- or lung-sensitisers, completely depends on animal testing. The overall objective of Sens-it-iv is to produce in vitro alternatives for these assays, and develop them upto the level of pre-validation. Besides reducing animal experimentation, an increase the accuracy of predicting sensitising potencies is expected. In vitro mechanisms, relevant for in vivo sensitisation, will be identified at the level of human lung or skin epithelial cells (EC), dendritic cells (DC) and T-cells.

These efforts imply specific scientific (S) and technologic (T) objectives:
a. Existing data on sensitising, irritating and toxic compounds are collected (S).
b. In vivo changes induced by selected compounds in the specified cell types are described using functional genomics (S).
c. Similarly, the impact of compounds on individual cells, and the interaction between these cells is assessed in vitro (S).
d. The physico-chemical properties of chemicals responsible for metabolic activation and hapten-formation are determined (S).
e. The data are collected in an Inductive Database allowing queries for data patterns and predictive models (T).
f. Mechanisms specifically involved in skin and respiratory sensitisation are identified using bio-informatics (S).
g. The information is used to adapt/improve existing techniques, and to develop organotypic models derived from human cells assays (T).
h. A proof of principle is established on a set of selected skin and respiratory sensitisers, irritants and toxic compounds (T).

Sens-it-iv is innovative primarily by the coordinated and extensive characterisation of the impact of compounds on cell-cell interactions for identification of the key mechanisms of sensitisation. Consistency with existing and ongoing projects, and optimal exploitation of these achievements is ensured by the involvement of ECVAM, COLIPA, ECOPA, IVTIP and OECD in various levels of the project.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

FP6-2004-LIFESCIHEALTH-5
See other projects for this call

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

IP - Integrated Project

Coordinator

NOVOZYMES SA
EU contribution
No data
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

No data

Participants (28)

My booklet 0 0